Skip to content
GLP-1 Scorecard
Menu
Site position #328

HumeCare+

By GLP-1 ScorecardUpdated

Pairs advertised GLP-1 care with connected body-composition tracking, while public pages differ on payment periods, delivery and refund promises.

Our take

HumeCare+ combines advertised GLP-1 care with a body-composition device and app. Its $199 headline needs a payment-calendar check: the homepage labels a three-month plan while another page describes monthly billing. We would confirm a shorter commitment and the full medication-and-care bill before prepaying, especially because its refund advertisements do not match the current terms clearly.

Visit HumeCare+We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
GLP-1 page advertises $199 billed monthly and a first four-week supply; homepage labels a three-month plan from $199/month. Confirm the selected total and formulation additions.
Tirzepatide
Named on the public GLP-1 menu, but no separate current public prescription price confirmed; obtain the selected medication and renewal quote.
Coverage
Homepage/footer exclude Louisiana and Mississippi; GLP-1 FAQ also excludes Alabama. Confirm current treatment-specific eligibility, especially Alabama.
Brand-name
Not confirmed

Weigh HumeCare+ against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

The homepage advertises a three-month plan from $199/month; the GLP-1 page says $199 billed monthly and a first four-week supply. The oral page advertises from $7/day. Exact selected totals, renewal amounts and possible medication or formulation additions require confirmation.

Choose the purchase period before choosing the package

HumeCare+ is easiest to understand as a medication-and-tracking package, but its public pages do not give one consistent payment calendar. The homepage advertises a three-month plan starting at $199 a month. A separate GLP-1 page instead says $199 billed monthly and describes a first four-week supply. Neither presentation establishes which initial total a particular buyer will authorize.

The October 2026 terms allow monthly, quarterly, semiannual and annual billing, with the full prepaid amount disclosed when selected. Do not assume that three advertised months mean three separate payments, or that multiplying $199 by three gives the actual debit. Obtain the selected total, included treatment period and next renewal amount together before comparing another provider.

The consultation is included, but additions remain possible

The homepage marks the consultation and one-to-one doctor support as free within its package. More usefully, the current terms describe one subscription price containing platform access and, where applicable, consultation and prescribed medication fulfilled through its partners. Those terms do not establish a separate enrollment or every-refill consultation charge.

They do allow additional charges for some medications, doses, formulations or fulfillment choices, with disclosure and express consent before charging. Ask whether the proposed prescription changes the advertised price and whether any laboratory work or other required service costs extra. The promise of a single membership bill is useful only when its selected inclusions and possible additions are clear.

Buy the tracking for its usefulness, not a muscle guarantee

The homepage includes a Hume Pod and app at no extra charge in the advertised package. Other plans may include devices or sell them separately under the terms. Someone who wants regular body-composition readings, food logging and medication tracking may find that combination convenient. Confirm whether hardware and app access remain included at renewal, rather than treating the displayed savings as cash returned to you.

The stronger promise needs more caution. HumeCare+ advertises muscle-preservation and weight-loss advantages, citing internal member analyses. Its terms describe device data as non-diagnostic, informational context shared with clinicians only with separate consent. Those readings and marketing comparisons do not demonstrate that the package, added vitamins or a particular compounded prescription will preserve your muscle or reduce side effects.

Confirm the actual medication and route

The GLP-1 page identifies compounded semaglutide and tirzepatide, but its general $199 program price does not settle a tirzepatide prescription quote. It also does not provide a complete ingredient label, concentration, vial volume or usable dose count. Ask which molecule and formulation are prescribed, what one shipment contains and whether dose changes affect the charge.

A separate oral-protocol page currently advertises an introductory offer from $7 a day. That is not a selected monthly invoice or a complete description of the active ingredient and dosage form. The safety page discusses several preparations, but an explanation there does not establish that each is available in your plan. The terms explicitly distinguish compounded preparations from FDA-approved products; a shared drug name does not establish equivalent clinical results.

There is a named clinical network, but assignment still matters

The current terms identify Hume Health Care LLC as the technology and administrative platform. Its public directory names MDI Medical Group PC as the contracted clinical network and lists clinicians and license numbers for Massachusetts, Rhode Island and Vermont. The same terms also refer to Junction and Openloop Healthcare Partners, PC in the telehealth consent, so ask which practice will actually provide your care. A public directory is more useful than an unnamed care team, but it does not identify the professional assigned to you or independently verify every listed license today.

North Carolina’s medical board lists MDI Medical Group, PC among active corporations. A corporate entry is not an individual physician license or nationwide clinical authorization. Obtain your treating clinician’s name and relevant current license. Also ask which patient tests are required, who reviews them and what they cost: a body-composition scan is not an itemized laboratory-testing benefit. No pharmacy facility is named in these terms or the shipping policy, so request the actual dispenser and physical compounder separately.

Confirm your state and leave time for processing

The GLP-1 page’s eligibility answer excludes Alabama, Louisiana and Mississippi. Its footer, like the homepage, names only Louisiana and Mississippi. The terms make availability depend on physician coverage and say the app shows current eligibility. Alabama therefore needs a direct answer for the selected treatment; neither public list establishes a prescription or pharmacy’s authority to serve your address.

The homepage advertises free next-day delivery. The shipping policy instead estimates physician review in one to two business days, pharmacy processing in three to five business days after prescription, then default two-day delivery. Hardware has a separate seven-to-ten-business-day shipping estimate. These are different stages and promises. Ask for the total expected time to usable medication, not just the carrier service after dispatch.

Get the refund promise attached to your purchase

The homepage displays a ninety-day money-back guarantee and separately promises a refund if a patient does not lose ten percent of body weight in six months. The oral page adds a 180-day promise. Those advertisements are not interchangeable eligibility rules, and the linked October 20 terms do not provide a results-guarantee clause explaining how to claim them.

Those terms promise a refund of the paid membership period within ten business days if the initial evaluation finds you ineligible for any treatment. Rejection for one GLP-1 does not by itself meet that condition. An included device may be kept or returned at Hume’s expense without reducing that refund. Customer-canceled prepaid terms receive no prorated refund; the older shipping policy also excludes ineligibility involving false or incomplete health information. Confirm the applicable promise before relying on repayment.

Our choice would start with a shorter commitment

The terms allow cancellation through the account’s Subscription section or support email before renewal, with access continuing through a paid prepaid term. Canceling future billing does not itself recover its unused value. The shipping policy separately allows an authorized hardware return within forty-five days, but says an included free device has no separate device refund. A device return is therefore not a membership exit guarantee.

HumeCare+ may appeal if you actively want the connected tracking system and can obtain a clear medication-and-care bill. We would prefer a confirmed shorter billing choice while the public payment and refund promises remain inconsistent. Before a longer commitment, settle usable supply, any additions, the assigned clinician and pharmacy, and the written refund terms. We have not used HumeCare+ treatment or tested its devices or delivery.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value54/100
Dose & formulation52/100
Clinical oversight71/100
Labs & monitoring53/100
Fulfillment64/100
Contract terms61/100

Strengths

  • Advertises a Hume Pod and app within the homepage package; other selected plans may differ
  • Current terms describe a single subscription including consultation and prescribed fulfilled medication, with added charges requiring disclosure and consent
  • Publicly identifies MDI Medical Group PC as the clinical network and provides a clinician directory; assignment and current individual licenses still need confirmation
  • Terms allow cancellation before renewal through the account Subscription section or support email

What to consider

  • Homepage three-month pricing and the GLP-1 page’s monthly billing description do not establish one selected initial charge or renewal calendar
  • Ninety-day, 180-day and six-month results-refund advertisements do not have matching claim rules in the current terms; customer-canceled prepaid periods are not prorated
  • Muscle-preservation, side-effect and outcome advantages are merchant claims, not established benefits of the prescribed compound or tracking device
  • No exact prescribing dose, vial quantity, usable supply or patient-lab price is confirmed by the public package
  • The dispensing pharmacy and physical compounder are not named in the reviewed terms or shipping policy
  • Alabama availability differs between the GLP-1 FAQ and site footer; general eligibility does not guarantee every preparation
  • Next-day advertising differs from published clinical-review, pharmacy-processing and carrier estimates; a free included device does not create a separate device cash refund

Bottom line — Grade C

Best for: Adults who want a connected tracking system alongside care and can confirm their full prescription price, billing period, assigned clinician and pharmacy before buying.

Look elsewhere if: People choosing mainly for a guaranteed muscle-preservation result, a settled money-back promise or a fully specified prescription at the lowest headline price. The public information does not establish those assurances.

Site position #328 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest HumeCare+ — the realistic shortlist.

The 24 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect HumeCare+'s public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on HumeCare+'s site. Not medical advice; see our disclosure.

← Back to the scorecard